CEREVEL THERAPEUTICS HLDNG I - COM (CERE) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2024

Type / Class
Equity / COM
Symbol
CERE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$20,686 0
2024 Q3 472 $20,686 -$6,270,635,727 $42.89 2
2024 Q2 156,912,856 $6,416,262,984 +$54,854,564 $40.89 229
2024 Q1 156,709,131 $6,624,104,038 +$38,698,690 $42.27 206
2023 Q4 155,825,420 $6,607,017,889 +$715,717,508 $42.40 192
2023 Q3 140,765,439 $3,072,997,298 +$11,248,312 $21.83 119
2023 Q2 138,547,005 $4,404,414,365 +$104,896,124 $31.79 123
2023 Q1 135,381,867 $3,301,334,034 +$30,753,772 $24.39 116
2022 Q4 133,993,715 $4,226,184,097 +$34,062,034 $31.54 124
2022 Q3 133,018,862 $3,759,011,024 +$195,085,542 $28.26 112
2022 Q2 124,149,327 $3,282,766,187 +$52,536,882 $26.44 105
2022 Q1 122,083,763 $4,273,265,376 +$122,403,720 $35.01 102
2021 Q4 118,590,412 $3,844,684,247 -$14,284,535 $32.42 104
2021 Q3 119,109,134 $3,513,732,753 +$482,150,677 $29.50 92
2021 Q2 103,309,752 $2,646,654,588 +$101,543,635 $25.62 81
2021 Q1 99,881,037 $1,371,362,373 +$40,180,822 $13.73 60
2020 Q4 96,549,099 $1,598,552,000 +$1,564,771,001 $16.58 55